EdgarLookup

Torrid Holdings Inc. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that Torrid Holdings Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
-0.7%
Profit Margin
Net income ÷ revenue
-1.8%
Return on Assets
Net income ÷ assets
-2.88x
Debt-to-Equity
Total liabilities ÷ equity
-9.4%
Revenue Growth
Year over year

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $1.00B Mar 31, 2026
FY2025 Feb 1, 2025 $1.10B Mar 31, 2026
FY2025 Feb 3, 2024 $1.15B Mar 31, 2026
FY2022 Jan 28, 2023 $301.23M Mar 28, 2023
FY2022 Oct 29, 2022 $300.20M Mar 28, 2023
FY2022 Jul 30, 2022 $353.52M Mar 28, 2023
FY2022 Apr 30, 2022 $333.19M Mar 28, 2023
FY2022 Jan 29, 2022 $318.65M Mar 28, 2023
FY2022 Oct 30, 2021 $310.89M Mar 28, 2023
FY2022 Jul 31, 2021 $337.51M Mar 28, 2023

Gross Profit

Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $347.96M Mar 31, 2026
FY2025 Feb 1, 2025 $413.47M Mar 31, 2026
FY2025 Feb 3, 2024 $405.98M Mar 31, 2026
FY2022 Jan 28, 2023 $96.18M Mar 28, 2023
FY2022 Oct 29, 2022 $101.94M Mar 28, 2023
FY2022 Jul 30, 2022 $131.49M Mar 28, 2023
FY2022 Apr 30, 2022 $129.93M Mar 28, 2023
FY2022 Jan 29, 2022 $103.88M Mar 28, 2023
FY2022 Oct 30, 2021 $129.80M Mar 28, 2023
FY2022 Jul 31, 2021 $154.36M Mar 28, 2023

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 ($7.03M) Mar 31, 2026
FY2025 Feb 1, 2025 $16.32M Mar 31, 2026
FY2025 Feb 3, 2024 $11.62M Mar 31, 2026
FY2024 Jan 28, 2023 $50.21M Apr 1, 2025
FY2023 Jan 29, 2022 ($29.94M) Apr 2, 2024
FY2022 Jan 30, 2021 $24.53M Mar 28, 2023
FY2021 Feb 1, 2020 $41.87M Mar 30, 2022

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $21.40M Mar 31, 2026
FY2025 Feb 1, 2025 $57.21M Mar 31, 2026
FY2025 Feb 3, 2024 $57.15M Mar 31, 2026
FY2022 Jan 28, 2023 $2.52M Mar 28, 2023
FY2022 Oct 29, 2022 $19.95M Mar 28, 2023
FY2022 Jul 30, 2022 $39.42M Mar 28, 2023
FY2022 Apr 30, 2022 $39.74M Mar 28, 2023
FY2022 Jan 29, 2022 $16.21M Mar 28, 2023
FY2022 Oct 30, 2021 $43.73M Mar 28, 2023
FY2022 Jul 31, 2021 ($40.05M) Mar 28, 2023

SG&A Expense

Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $269.18M Mar 31, 2026
FY2025 Feb 1, 2025 $302.03M Mar 31, 2026
FY2025 Feb 3, 2024 $293.33M Mar 31, 2026
FY2022 Jan 28, 2023 $77.84M Mar 28, 2023
FY2022 Oct 29, 2022 $69.35M Mar 28, 2023
FY2022 Jul 30, 2022 $78.57M Mar 28, 2023
FY2022 Apr 30, 2022 $72.22M Mar 28, 2023
FY2022 Jan 29, 2022 $70.29M Mar 28, 2023
FY2022 Oct 30, 2021 $71.05M Mar 28, 2023
FY2022 Jul 31, 2021 $183.68M Mar 28, 2023

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 ($13.01M) Mar 31, 2026
FY2025 Feb 1, 2025 $77.39M Mar 31, 2026
FY2025 Feb 3, 2024 $42.77M Mar 31, 2026
FY2024 Jan 28, 2023 $53.31M Apr 1, 2025
FY2023 Jan 29, 2022 $121.22M Apr 2, 2024
FY2022 Jan 30, 2021 $151.82M Mar 28, 2023
FY2021 Feb 1, 2020 $99.09M Mar 30, 2022

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $8.85M Mar 31, 2026
FY2025 Feb 1, 2025 $14.39M Mar 31, 2026
FY2025 Feb 3, 2024 $26.00M Mar 31, 2026
FY2024 Jan 28, 2023 $23.37M Apr 1, 2025
FY2023 Jan 29, 2022 $17.55M Apr 2, 2024
FY2022 Jan 30, 2021 $11.57M Mar 28, 2023
FY2021 Feb 1, 2020 $26.33M Mar 30, 2022

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $400.34M Mar 31, 2026
FY2025 Feb 1, 2025 $488.44M Mar 31, 2026
FY2024 Feb 3, 2024 $476.95M Apr 1, 2025
FY2023 Jan 28, 2023 $527.26M Apr 2, 2024
FY2022 Jan 29, 2022 $578.50M Mar 28, 2023
FY2021 Jan 30, 2021 $648.21M Mar 30, 2022

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $613.75M Mar 31, 2026
FY2025 Feb 1, 2025 $679.53M Mar 31, 2026
FY2024 Feb 3, 2024 $688.66M Apr 1, 2025
FY2023 Jan 28, 2023 $757.49M Apr 2, 2024
FY2022 Jan 29, 2022 $836.82M Mar 28, 2023
FY2021 Jan 30, 2021 $711.38M Mar 30, 2022

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 ($213.41M) Mar 31, 2026
FY2025 Feb 1, 2025 ($191.09M) Mar 31, 2026
FY2025 Feb 3, 2024 ($211.72M) Mar 31, 2026
FY2025 Jan 28, 2023 ($230.22M) Mar 31, 2026
FY2024 Jan 29, 2022 ($258.32M) Apr 1, 2025
FY2023 Jan 30, 2021 ($63.17M) Apr 2, 2024
FY2022 Feb 1, 2020 ($95.50M) Mar 28, 2023
FY2021 Feb 2, 2019 $126.42M Mar 30, 2022

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 ($338.30M) Mar 31, 2026
FY2025 Feb 1, 2025 ($331.27M) Mar 31, 2026
FY2024 Feb 3, 2024 ($347.59M) Apr 1, 2025
FY2023 Jan 28, 2023 ($359.21M) Apr 2, 2024
FY2022 Jan 29, 2022 ($377.76M) Mar 28, 2023
FY2021 Jan 30, 2021 ($74.59M) Mar 30, 2022

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $20.02M Mar 31, 2026
FY2025 Feb 1, 2025 $48.52M Mar 31, 2026
FY2024 Feb 3, 2024 $11.74M Apr 1, 2025
FY2023 Jan 28, 2023 $13.57M Apr 2, 2024
FY2022 Jan 29, 2022 $29.03M Mar 28, 2023
FY2021 Jan 30, 2021 $122.95M Mar 30, 2022

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $272.41M Mar 31, 2026
FY2025 Feb 1, 2025 $288.55M Mar 31, 2026

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 0 Mar 31, 2026
FY2025 Feb 1, 2025 0 Mar 31, 2026
FY2025 Feb 3, 2024 0 Mar 31, 2026
FY2024 Jan 28, 2023 0 Apr 1, 2025
FY2023 Jan 29, 2022 0 Apr 2, 2024
FY2022 Jan 30, 2021 0 Mar 28, 2023
FY2021 Feb 1, 2020 0 Mar 30, 2022

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 0 Mar 31, 2026
FY2025 Feb 1, 2025 0 Mar 31, 2026
FY2025 Feb 3, 2024 0 Mar 31, 2026
FY2024 Jan 28, 2023 0 Apr 1, 2025
FY2023 Jan 29, 2022 0 Apr 2, 2024
FY2022 Jan 30, 2021 0 Mar 28, 2023
FY2021 Feb 1, 2020 0 Mar 30, 2022

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 99.31M Mar 31, 2026
FY2025 Feb 1, 2025 104.86M Mar 31, 2026
FY2024 Feb 3, 2024 104.20M Apr 1, 2025
FY2023 Jan 28, 2023 103.77M Apr 2, 2024
FY2022 Jan 29, 2022 107.86M Mar 28, 2023
FY2021 Jan 30, 2021 110.00M Mar 30, 2022